An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria

BACKGROUND: Artesunate+amodiaquine (AS+AQ) and artemether-lumefantrine (AL) are now the most frequently recommended first line treatments for uncomplicated malaria in Africa. Artesunate+chlorproguanil-dapsone (AS+CD) was a potential alternative for treatment of uncomplicated malaria. A comparison of...

Descripción completa

Detalles Bibliográficos
Autores principales: Owusu-Agyei, Seth, Asante, Kwaku Poku, Owusu, Ruth, Adjuik, Martin, Amenga-Etego, Stephen, Dosoo, David Kwame, Gyapong, John, Greenwood, Brian, Chandramohan, Daniel
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430614/
https://www.ncbi.nlm.nih.gov/pubmed/18575626
http://dx.doi.org/10.1371/journal.pone.0002530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430614/
https://www.ncbi.nlm.nih.gov/pubmed/18575626
http://dx.doi.org/10.1371/journal.pone.0002530

Ejemplares similares